ORAI1 and experimental autoimmune encephalomyelitis: As with ORAI1, experimental autoimmune encephalomyelitis was ameliorated by inhibition of Kv1.3 alone, or of both Kv1.3 and KCa3.1, in CD4+ T-lymphocytes [31].